Literature DB >> 29577371

Role of T-bet, the master regulator of Th1 cells, in the cytotoxicity of murine CD4+ T cells.

Koji Eshima1, Kana Misawa1, Chihiro Ohashi1, Kazuya Iwabuchi1.   

Abstract

Although CD4+ T cells are generally regarded as helper T cells, some activated CD4+ T cells have cytotoxic properties. Given that CD4+ cytotoxic T lymphocytes (CTLs) often secrete IFN-γ, CTL activity among CD4+ T cells may be attributable to Th1 cells, where a T-box family molecule, T-bet serves as the "master regulator". However, although the essential contribution of T-bet to expression of IFN-γ has been well-documented, it remains unclear whether T-bet is involved in CD4+ T cell-mediated cytotoxicity. In this study, to investigate the ability of T-bet to confer cytolytic activity on CD4+ T cells, the T-bet gene (Tbx21) was introduced into non-cytocidal CD4+ T cell lines and their cytolytic function analyzed. Up-regulation of FasL (CD178), which provided the transfectant with cytotoxicity, was observed in Tbx21transfected CD4+ T cells but not in untransfected parental cells. In one cell line, T-bet transduction also induced perforin gene (Prf1) expression and Tbx21 transfectants efficiently killed Fas- target cells. Although T-bet was found to repress up-regulation of CD40L (CD154), which controls FasL-mediated cytolysis, the extent of CD40L up-regulation on in vitro-differentiated Th1 cells was similar to that on Th2 cells, suggesting the existence of a compensatory mechanism. These results collectively indicate that T-bet may be involved in the expression of genes, such as FasL and Prf1, which confer cytotoxicity on Th1 cells.
© 2018 The Societies and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  FasL (CD178); T-bet; cytotoxicity; perforin

Mesh:

Substances:

Year:  2018        PMID: 29577371     DOI: 10.1111/1348-0421.12586

Source DB:  PubMed          Journal:  Microbiol Immunol        ISSN: 0385-5600            Impact factor:   1.955


  5 in total

1.  A global immune gene expression signature for human cancers.

Authors:  Yuexin Liu
Journal:  Oncotarget       Date:  2019-03-08

Review 2.  Essential Kinases and Transcriptional Regulators and Their Roles in Autoimmunity.

Authors:  Ya Nan Deng; Joseph A Bellanti; Song Guo Zheng
Journal:  Biomolecules       Date:  2019-04-10

Review 3.  When Helpers Go Above and Beyond: Development and Characterization of Cytotoxic CD4+ T Cells.

Authors:  Cindy Hoeks; Gayel Duran; Niels Hellings; Bieke Broux
Journal:  Front Immunol       Date:  2022-07-12       Impact factor: 8.786

Review 4.  Therapeutic targeting of VEGF and/or TGF-β to enhance anti-PD-(L)1 therapy: The evidence from clinical trials.

Authors:  Linwei Li; Qinglian Wen; Ruilin Ding
Journal:  Front Oncol       Date:  2022-07-26       Impact factor: 5.738

5.  JAK/STAT-Dependent Chimeric Antigen Receptor (CAR) Expression: A Design Benefiting From a Dual AND/OR Gate Aiming to Increase Specificity, Reduce Tumor Escape and Affect Tumor Microenvironment.

Authors:  Javad Khanali; Mohammadreza Azangou-Khyavy; Melika Boroomand-Saboor; Mobina Ghasemi; Hassan Niknejad
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.